These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18336997)

  • 21. Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer.
    Westphalen AA; Russell AM; Buser M; Berthod CR; Hutter P; Plasilova M; Mueller H; Heinimann K
    Hum Genet; 2005 May; 116(6):461-5. PubMed ID: 15772852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.
    Talseth BA; Ashton KA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Int J Cancer; 2008 Mar; 122(6):1273-7. PubMed ID: 18027856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 17A1 and catechol O-methyltransferase polymorphisms and age at Lynch syndrome colon cancer onset in Newfoundland.
    Campbell PT; Edwards L; McLaughlin JR; Green J; Younghusband HB; Woods MO
    Clin Cancer Res; 2007 Jul; 13(13):3783-8. PubMed ID: 17606708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer.
    Krüger S; Engel C; Bier A; Mangold E; Pagenstecher C; Doeberitz Mv; Holinski-Feder E; Moeslein G; Keller G; Kunstmann E; Friedl W; Plaschke J; Rüschoff J; Schackert HK;
    Cancer Lett; 2006 May; 236(2):191-7. PubMed ID: 16832876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients.
    Talseth-Palmer BA; Holliday EG; Evans TJ; McEvoy M; Attia J; Grice DM; Masson AL; Meldrum C; Spigelman A; Scott RJ
    BMC Med Genomics; 2013 Mar; 6():10. PubMed ID: 23531357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Aurora-A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population.
    Chen J; Sen S; Amos CI; Wei C; Jones JS; Lynch P; Frazier ML
    Mol Carcinog; 2007 Apr; 46(4):249-56. PubMed ID: 17219423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A parametric model for analyzing anticipation in genetically predisposed families.
    Larsen K; Petersen J; Bernstein I; Nilbert M
    Stat Appl Genet Mol Biol; 2009; 8():Article26. PubMed ID: 19492984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominantly Inherited Hereditary Nonpolyposis Colorectal Cancer Not Caused by MMR Genes.
    Terradas M; Capellá G; Valle L
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32585810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
    Win AK; Hopper JL; Buchanan DD; Young JP; Tenesa A; Dowty JG; Giles GG; Goldblatt J; Winship I; Boussioutas A; Young GP; Parry S; Baron JA; Duggan D; Gallinger S; Newcomb PA; Haile RW; Le Marchand L; Lindor NM; Jenkins MA
    Eur J Cancer; 2013 May; 49(7):1578-87. PubMed ID: 23434150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of MLH1 I219V polymorphism in unrelated South American individuals suspected of having Lynch syndrome.
    Valentin MD; Da Silva FC; Santos EM; Da Silva SD; De Oliveira Ferreira F; Aguiar Junior S; Gomy I; Vaccaro C; Redal MA; Della Valle A; Sarroca C; Rasmussen LJ; Carraro DM; Rossi BM
    Anticancer Res; 2012 Oct; 32(10):4347-51. PubMed ID: 23060557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
    Talseth-Palmer BA; Wijnen JT; Brenne IS; Jagmohan-Changur S; Barker D; Ashton KA; Tops CM; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; ; Spigelman A; Møller P; Morreau HM; Van Wezel T; Lubinski J; Vasen HF; Scott RJ
    Int J Cancer; 2013 Apr; 132(7):1556-64. PubMed ID: 22987364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome.
    Bellido F; Guinó E; Jagmohan-Changur S; Seguí N; Pineda M; Navarro M; Lázaro C; Blanco I; Vasen HF; Moreno V; Capellá G; Wijnen JT; Valle L
    Eur J Hum Genet; 2013 May; 21(5):511-6. PubMed ID: 22948024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
    Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers.
    Houlle S; Charbonnier F; Houivet E; Tinat J; Buisine MP; Caron O; Benichou J; Baert-Desurmont S; Frebourg T
    Eur J Hum Genet; 2011 Aug; 19(8):887-92. PubMed ID: 21407259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome.
    Castillejo A; Guarinos C; Martinez-Canto A; Barbera VM; Egoavil C; Castillejo MI; Perez-Carbonell L; Sanchez-Heras AB; Segura A; Ochoa E; Lazaro R; Ruiz-Ponte C; Bujanda L; Andreu M; Castells A; Carracedo A; Llor X; Clofent J; Alenda C; Paya A; Jover R; Soto JL
    BMC Med Genet; 2011 Jan; 12():12. PubMed ID: 21247423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.
    Talseth-Palmer BA; Brenne IS; Ashton KA; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Lubinski J; Scott RJ
    J Med Genet; 2011 Apr; 48(4):279-84. PubMed ID: 21097774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHEK2 mutations and HNPCC-related colorectal cancer.
    Suchy J; Cybulski C; Wokołorczyk D; Oszurek O; Górski B; Debniak T; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dziuba I; Gogacz M; Wiśniowski R; Wandzel P; Banaszkiewicz Z; Kurzawski G; Kładny J; Narod SA; Lubiński J
    Int J Cancer; 2010 Jun; 126(12):3005-9. PubMed ID: 19876921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome.
    Chen J; Etzel CJ; Amos CI; Zhang Q; Viscofsky N; Lindor NM; Lynch PM; Frazier ML
    Cancer Causes Control; 2009 Nov; 20(9):1769-77. PubMed ID: 19690970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age.
    Shi Z; Johnstone D; Talseth-Palmer BA; Evans TJ; Spigelman AD; Groombridge C; Milward EA; Olynyk JK; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Int J Cancer; 2009 Jul; 125(1):78-83. PubMed ID: 19291797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.
    Reeves SG; Meldrum C; Groombridge C; Spigelman AD; Suchy J; Kurzawski G; Lubinski J; McElduff P; Scott RJ
    Eur J Hum Genet; 2009 May; 17(5):629-35. PubMed ID: 19156174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.